Galderma's Nemluvio® (Nemolizumab) Approved In The European Union For Moderate-To-Severe Atopic Dermatitis And Prurigo N...
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...
Armed robbery in Revesby7h
EU Greenlights Galderma's Nemluvio for Skin Conditions
Ad hoc announcement pursuant to Art. 53 LR This approval from the European Commission is based on robust results from the phase III OLYMPIA and ...
Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...
The EMBO Journal1d
Portimine A toxin causes skin inflammation through ZAKα-dependent NLRP1 inflammasome activation
In 2020-2021, a mysterious skin disease affected fishermen in Senegal. High levels of Portimine A toxin, produced by the ...
Implantica announces positive feedback received from U.S. FDA of the RefluxStopâ„¢ PMA Module 2 submission
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique ...
Us Weekly1d
This Calming Barrier Cream Is a ‘Game Changer’ for Beating Winter Skin — And It’s 27% Off Today
The lightweight yet intensely moisturizing formula is packed with five types of centella asiatica (aka cica) to soothe skin ...
Scientists develop novel self-healing electronic skin for health monitoring
Researchers have achieved a breakthrough in wearable health technology by developing a novel self-healing electronic skin ...